Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patients have good recall on lung cancer screening scan benefits, not risks

Publish date:: October 26, 2019

Key clinical point: Patients tend to recall the benefits of lung cancer screening much more than the risks, underscoring the need for ongoing patient education beyond the initial shared decision-making encounter.

Major finding: About 9 in 10 patients recalled key information on the benefits, but only about 4 in 10 recalled information on risks.

Study details: Survey of 228 patients who had a baseline screening CT scan 6-12 months earlier.

Disclosures: Study authors reported no relevant relationships.

Citation:

Hirsch E et al. CHEST 2019. Abstract, doi: 10.1016/j.chest.2019.08.107.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Lung Cancer

Two different radiation boost strategies reduce local failures in NSCLC,

Rechallenge ‘reasonable’ for some with small-cell lung cancer,

Black patients with ES-SCLC get less chemo but have better survival,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Reduced cancer mortality with Medicaid expansion,